Catalyst Funds Management’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,000
Closed -$29K 1142
2024
Q3
$29K Buy
+2,000
New +$29K 0.01% 993